The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global enteric softgel capsules market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Enteric softgel capsules are extended-release capsules used to stabilize the reaction of acid-sensitive medicine in the human stomach during digestion. These capsules are hermetically sealed and contain liquid or semi-solid medicinal drugs enclosed in gelatin-based shell coating. The coating delays the release, improves tolerance and reduces poor aftertastes of the enclosed product. These capsules protect the active pharmaceutical ingredients (API) and prevent gastric irritation and reflux. They are commonly used in the form of multivitamin supplements to treat or prevent vitamin and nutrient deficiency due to poor diet, illnesses or during pregnancy. In comparison to the traditionally used capsules, enteric softgel variants offer preserved enzyme activity and enhanced bioavailability, absorption and efficacy.
Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, rising health consciousness among the masses and the increasing acceptance of nutritional and dietary supplements are providing a thrust to the growth of the market. Enteric softgel capsules are widely used to enclose Omega-3 oils and other gel-based supplements. Additionally, various product innovations, such as the development of non-gelatin-based enteric softgel capsules, are acting as other growth-inducing factors. Novel variants are being manufactured using starch and other plant-based sources to meet the requirements of consumers with vegan dietary preferences. In line with this, the rising geriatric population, which is more susceptible to chronic medical ailments and the proliferation of online pharmacies through ecommerce retail channels are also contributing to the market growth. Other factors, including rising healthcare expenditures of the consumers, along with extensive research and development (R&D) activities to improve the bioavailability of these capsules, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global enteric softgel capsules market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, application and distribution channel.
Breakup by Type:
Breakup by Application:
Breakup by Distribution Channel:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aenova Group, BASF SE , Catalent Inc, Colorcon Inc., Fuji Capsule Co. Ltd., Lonza Group AG, NOW Foods, ProCaps, Super Spectrim and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2020|
|Segment Coverage||Type, Application, Distribution Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Aenova Group, BASF SE, Catalent Inc, Colorcon Inc., Fuji Capsule Co. Ltd., Lonza Group AG, NOW Foods, ProCaps, Super Spectrim and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at